Back
Hoth Therapeutics, Inc. 10K Form
Sell
7
HOTH
Hoth Therapeutics, Inc.
Last Price:
$0.57
Seasonality Move:
0.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HOTH News And Ratings
See the #1 stock for the next 7 days that we like better than HOTH
HOTH Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.40 |
| Price / Book: | 1.49 |
Profitability
| EPS (TTM): | -0.91110 |
|---|---|
| Net Income (TTM): | $-12.5M |
| Gross Margin: | $0 |
| Return on Equity: | -146.54% |
| Return on Assets: | -132.59% |
Hoth Therapeutics, Inc. Earnings Forecast
Key Hoth Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 9 years have been positive in 5 years.
Hoth Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | HOTH |
| CUSIP: | 44148G |
| Website: | hoththerapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.68 |
| Quick Ratio: | 4.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HOTH Technical Analysis vs Fundamental Analysis
Sell
7
Hoth Therapeutics, Inc. (HOTH)
is a Sell
Is Hoth Therapeutics, Inc. a Buy or a Sell?
-
Hoth Therapeutics, Inc. stock is rated a SellThe current Hoth Therapeutics, Inc. [HOTH] share price is $0.56. The Score for HOTH is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.